New approaches to personalized cancer care
It is predicted there will be 28 million new cancer cases worldwide each year by 20401. Prioritizing precision oncology is more important than ever, with theranostics—enabled by PET/CT and SPECT/CT—at the center of this transition.

Adoption of cardiac PET/CT
Cardiovascular disease remains the leading cause of death globally.2 Cardiac PET/CT is gaining traction for its high diagnostic accuracy and efficiency and is increasingly becoming the standard for bringing advanced cardiac care to more patients.

Emerging therapies for Alzheimer’s disease
Over 7 million Americans currently have Alzheimer’s.3 As disease-modifying therapies become more widely available, PET/CT is a valuable tool for confidently assessing disease progression and guiding treatment decisions.
